Vote Green for MediPharm: Glass Lewis Endorses Board Nominees

Glass Lewis Recommendation for MediPharm Shareholders

MediPharm Labs Corp. (NASDAQ: LABS), a leader in the pharmaceutical sector focusing on precision cannabinoids, is receiving endorsements that are pivotal for its governance. An influential independent advisory firm, Glass Lewis & Co., has recently recommended that shareholders should support the company's nominees for the Board of Directors. This guidance comes ahead of an important meeting that is aimed at ensuring a stable and experienced leadership team for the future.

The Importance of a Consistent Vote

In its report, established on a thorough analysis, Glass Lewis suggests that investors vote using the GREEN proxy, emphasizing that it's vital for shareholders to voice their support this way. This marks the second endorsement from a prominent proxy advisory firm, following an earlier recommendation from Institutional Shareholder Services (ISS). These endorsements highlight the importance of a unified and informed voting strategy in shaping the direction of MediPharm Labs.

Encouraging Shareholder Participation

MediPharm urges all shareholders to actively participate by voting with the GREEN proxy specifically designated for the upcoming Annual and Special Meeting. The company has set a deadline for votes to be counted, which is at 3:00 p.m. Eastern time to ensure every voice is heard. To facilitate transparent voting, shareholders are encouraged to contact their brokers for their unique control numbers linked to the GREEN proxy.

Disregarding Misleading Communications

As the voting date approaches, some shareholders may encounter outreach from a dissident group. MediPharm advises to disregard these communications and focus solely on voting with the GREEN proxy to support the company's goals and values.

About MediPharm Labs

Founded in 2015, MediPharm Labs has positioned itself at the forefront of cannabis innovation. The company's focus is on developing and manufacturing purified cannabis concentrates that adhere to the highest quality standards. Operating from facilities certified by Good Manufacturing Practices and ISO standards, MediPharm is dedicated to creating high-quality cannabis products that meet the needs of patients and customers, both domestically and internationally.

Recent Milestones and Expansion

In an impressive stride for the company, MediPharm received a Pharmaceutical Drug Establishment License from Health Canada in 2021, making it the only company in North America with a commercial-scale domestic GMP license for extracting multiple natural cannabinoids. This milestone has paved the way for potential international drug manufacturing collaborations, including registration with the U.S. FDA.

The recent acquisition of VIVO Cannabis Inc. further diversified MediPharm's offerings and broadened its patient reach. With this acquisition, MediPharm has access to medical platforms in Canada, Australia, and Germany — enhancing its ability to serve medical patients effectively. It also includes Harvest Medical Clinics, which provide invaluable educational resources and support for medical cannabis patients.

By ensuring compliance with all relevant laws, MediPharm Labs fosters trust and integrity in its operations, supporting its commitment to quality and safety.

Shareholder Voting Assistance

For shareholders requiring help with their GREEN proxy submissions, MediPharm has partnered with Sodali & Co. to provide assistance. Shareholders can contact Sodali via toll-free numbers depending on their location or email for any questions related to the voting process.

Investor and Media Contacts

MediPharm Labs welcomes inquiries regarding its operations, investments, or any company news. Investor relations are managed professionally, and communication channels remain open for stakeholder engagement.

Frequently Asked Questions

What is the purpose of the GREEN proxy?

The GREEN proxy is a voting tool for shareholders to support MediPharm's nominees for the Board of Directors, ensuring a cohesive governance approach.

Who recommended that shareholders vote for MediPharm's nominees?

Glass Lewis, an independent proxy advisory firm, recommended that shareholders vote with the GREEN proxy to support MediPharm's nominees.

What significant milestone did MediPharm achieve in 2021?

In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, allowing it to conduct advanced cannabinoid extraction legally.

How has MediPharm expanded its market reach recently?

MediPharm's acquisition of VIVO Cannabis Inc. has allowed it to extend its reach to medical patients through various channels in Canada, Australia, and Germany.

What assistance is available for shareholders during the voting process?

Shareholders can contact Sodali & Co. for guidance and assistance with executing their GREEN proxy or voting instructions.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.